doi: 10.3389/fimmu.2025.1602235 Received 29 March 2025 Accepted 19 May 2025 Published 04 June 2025 Volume 16 - 2025 Edited by Yali Zheng, Xiamen University, China Reviewed by Hong Yu, Nanyang Technological University, Singapore Jiaxin Ma, Xiamen University, China Updates Copyright 2025 Habiballah, Li and Jiang
If you use oral contraceptives : The effectiveness of oral contraceptives may be reduced when starting Mounjaro or increasing the dose
It builds a foundation for long-term success by allowing your digestive system, appetite centers, and metabolic pathways to adjust incrementally rather than all at once
As research continues, healthcare professionals remain optimistic about its potential long-term benefits for people living with type 2 diabetes
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Stanisavljevic I, Pavlovic S, Simovic Markovic B, Jurisevic M, Krajnovic T, Mijatovic S, Spasojevic M, Mitrovic S, Corovic I, Jovanovic I